Fig. 6.
Copy‐number increase and upregulation of TLK1 and MK5 in metastatic PCa. Bioinformatic analysis of PCa data sets to determine: (A) genomic alteration of MK5; (B) mRNA expression of TLK1 based on nodal metastasis; (C) mRNA expression of MK5 based on nodal metastasis; (D) mRNA expression of TLK1 based on tumour Gleason score; (E) mRNA expression of MK5 based on tumour Gleason score. CRPC= castration‐resistant prostate cancer, PRAD = prostate adenocarcinoma, NEPC = neuroendocrine prostate cancer. Box‐and‐whisker plots represent interquartile range (IQR) including minimum, 25th percentile, median, 75th percentile and maximum values. N0 = no regional lymph node metastasis and N1 = metastases in 1 to 3 axillary lymph nodes. GS = Gleason score. *=P < 0.05, **=P < 0.005 and ****=P < 0.0001.